BERENGUER, C., Grossmann, D., MASSART, F., ANTONY, P., Burbulla, L., GLAAB, E., Imhoff, S., Trinh, J., Seibler, P., GRÜNEWALD, A., & KRÜGER, R. (2019). Variants in Miro1 cause alterations of ER-mitochondria contact sites in fibroblasts from Parkinson's disease patients. Journal of Clinical Medicine. doi:10.3390/jcm8122226 Peer Reviewed verified by ORBi |
BERENGUER, C. (2019). PATHOGENIC ROLE OF PARKINSON’S DISEASE-ASSOCIATED MIRO1 MUTATIONS IN THE MITOCHONDRIAL-ENDOPLASMIC RETICULUM INTERPLAY [Doctoral thesis, Unilu - University of Luxembourg]. ORBilu-University of Luxembourg. https://orbilu.uni.lu/handle/10993/42939 |
GROSSMANN, D., BERENGUER, C., Bellet, M. E., Scheibner, D., Bohler, J., MASSART, F., Rapaport, D., SKUPIN, A., FOUQUIER D'HÉROUËL, A., Sharma, M., GHELFI, J., Rakovic, A., Lichtner, P., ANTONY, P., GLAAB, E., MAY, P., Dimmer, K. S., Fitzgerald, J. C., GRÜNEWALD, A., & KRÜGER, R. (2019). Mutations in RHOT1 disrupt ER-mitochondria contact sites interfering with calcium homeostasis and mitochondrial dynamics in Parkinson's disease. Antioxidants & redox signaling. doi:10.1089/ars.2018.7718 Peer reviewed |